DR. OMAR M LATTOUF, M.D.
Radiology at Peachtree St, Atlanta, GA

7513908, Apr 7, 2009

Nov 22, 2005

11/285469

Omar M. Lattouf - Atlanta GA, US

A61F 2/24

623 21

The invention is directed to two minimally invasive therapeutic procedures, particularly for patients with congestive heart failure, and devices and systems for such procedures. One procedure involves providing a valved passageway through the patient's left ventricular wall at the apex of the patient's heart and advancing instruments through the valved passageway to connect the valve leaflets of the patient's heart valve, e. g. the mitral valve, in a “Bow-Tie” configuration to prevent or minimize regurgitation through the valve. The second procedure involves advancing a pacing lead and a pacing lead implanting device through a trocar in the patient's chest and implanting the pacing lead on an exposed epicardial region of the patient's heart wall. The pacing lead has a penetrating electrode which is secured within the heart wall. One or both procedures may be performed on a patient with CHF.

2011014, Jun 16, 2011

Feb 23, 2011

13/033411

Omar M. Lattouf - Atlanta GA, US

Transcardiac Therapeutics, Inc. - Atlanta GA

A61F 2/24, A61N 1/362, A61B 17/28, A61N 1/05

623 211, 607 9, 606205, 607119

The invention is directed to two minimally invasive therapeutic procedures, particularly for patients with congestive heart failure, and devices and systems for such procedures. One procedure involves providing a valved passageway through the patient's left ventricular wall at the apex of the patient's heart and advancing instruments through the valved passageway to connect the valve leaflets of the patient's heart valve, e.g. the mitral valve, in a “Bow-Tie” configuration to prevent or minimize regurgitation through the valve. The second procedure involves advancing a pacing lead and a pacing lead implanting device through a trocar in the patient's chest and implanting the pacing lead on an exposed epicardial region of the patient's heart wall. The pacing lead has a penetrating electrode which is secured within the heart wall. One or both procedures may be performed on a patient with CHF.Improved devices for these procedures include a minimally invasive grasping device having an inner lumen for advancing connecting members and other instruments through the device to the distal end thereof. Other improved devices include a pacing lead implant instrument which is releasably secured by its distal end to the exposed heart wall to facilitate penetration of the pacing lead electrode into the heart wall. Other improved instruments include a leaflet connector with an artificial cordae tendenae strand secured to an end of the leaflet connector.

7373207, May 13, 2008

Dec 6, 2002

10/313198

Omar M. Lattouf - Atlanta GA, US

A61N 1/372

607130, 607 3, 607 4, 607 5, 607 9, 607 10, 607129, 607131, 600 16, 600 17

The invention is directed to devices for two minimally invasive therapeutic procedures, particularly for patients with congestive heart failure. One procedure involves providing a valve to form a passageway through the patient's left ventricular wall at the apex of the patient's heart and configured to advance instruments through the valved passageway to connect the valve leaflets of the patient's heart valve, e. g. the mitral valve, in a “Bow-Tie” configuration to prevent or minimize regurgitation through the valve. The second procedure is directed to a pacing lead with a housing and a pacing lead implanting device which are configured to pass through a trocar in the patient's chest and implanting the pacing lead on an exposed epicardial region of the patient's heart wall. The pacing lead has a penetrating electrode which is secured within the heart wall. One or both procedures may be performed on a patient with CHF.

2010008, Apr 8, 2010

Feb 15, 2008

12/527248

Omar Lattouf - Atlanta GA, US

EMORY UNIVERSITY - Atlanta GA

A61F 2/84, A61F 2/82

623 111, 623 124, 623 115

An endovascular stent and an aortic valve replacement can be used to treat the aorta. An endovascular stent suitable for treating the ascending aorta includes a circumferential wall with one or more portions configured to allow blood to flow therethrough, and one or more portions configured to be substantially impermeable. In one version, the blood-permeable portion is defined by bare metal with fenestrations defined therein, and the impermeable portion is formed from polymeric material. The permeable and impermeable portions of the stent are sized, shaped, and located so that, when positioned in the blood vessel to be treated, the impermeable portion is in operative proximity to an aneurysm, dissection, or other area to be treated, and the permeable, bare metal portion is in operative proximity to other blood vessels which need to receive blood from the blood vessel being treated. An aortic valve replacement includes multiple flanges that can be seated in the sinuses of valsalva. The stent or aortic valve replacement may be included in a suitable apparatus for treatment of the aorta. The apparatus for treating the aorta may include a delivery system adapted to be inserted through the apex of the left ventricle of the heart.

2004011, Jun 17, 2004

Sep 26, 2003

10/472972

Omar Lattouf - Atlanta GA, US

A61B017/06

606/224000

Needle-suture combinations are disclosed that include two surgical needles, each including an end having a suture-receiving aperture, and two sutures attached to the ends of each of the two needles. Also disclosed are methods for using the needle-suture combination, the method including passing through a first tissue and a second tissue two needle-suture combinations each having first and second needles connected to first and second sutures; pulling the sutures therethrough; disconnecting the needles from the sutures, thereby providing free ends on the sutures; tying the free ends of the first sutures of the first needle-suture combination together; and tying the free end of the second suture of the first needle-suture combination with the second suture of the second needle-suture combination. With the apparatus and/or method, elements joined together may form a more hemostatic seal.

2013025, Sep 26, 2013

Apr 26, 2013

13/871505

Omar M. Lattouf - Atlanta GA, US

Trans Cardiac Therapeutics, Inc. - Duluth GA

A61F 2/24

623 211

Two minimally invasive therapeutic procedures, particularly for patients with congestive heart failure, may be performed separately or together. One procedure involves providing a valved passageway through the patient's left ventricular wall at the apex of the patient's heart and advancing instruments through the valved passageway to connect the valve leaflets of the patient's heart valve, e.g. the mitral valve. The second procedure involves advancing a pacing lead and a pacing lead implanting device through a trocar in the patient's chest and implanting the pacing lead on an exposed epicardial region of the patient's heart wall. The pacing lead has a penetrating electrode which is secured within the heart wall. Improved devices for these procedures include a minimally invasive grasping device for heart leaflets, a leaflet connector with artificial cordae tendenae and a pacing lead implant instrument.

2007026, Nov 15, 2007

Jan 25, 2007

11/698643

Omar Lattouf - Atlanta GA, US

A61F 2/24

623002120

The invention is directed to percutaneous transvascular therapeutic procedures, particularly for patients with congestive heart failure, and systems for such procedures. A system of the invention for a “Bow-tie” procedure has an elongated guide catheter, a leaf stabilizing device and a tissue grasping device for grasping the free edges of the patient's heart valve slidably disposed within the guide catheter. Preferably, an artificial cordae tendenae is provided if a natural cordae tendenae of the patient has been torn.

2012020, Aug 9, 2012

Sep 28, 2011

13/247304

Omar M. Lattouf - Atlanta GA, US
Dirk Hoyns - Social Circle GA, US
Larry Hall - Atlanta GA, US
Amin Rahme - Atlanta GA, US

A61B 1/32

600208

The invention is directed to a method of treating a patient's heart. In this method an instrument port is secured within a passageway through a wall of an apical region of the patient's heart to allow the passage of a treatment instrument. A number of minimally invasive procedures may be performed within the patient's heart